1. Home/
  2. Compounds/
  3. tanespimycin:bortezomib (250:1 mol/mol)

tanespimycin:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tanespimycin:bortezomib (250:1 mol/mol)
PharmacoGx tanespimycin:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tanespimycin:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SRP9 CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA CYTH3 CTRPv2 pan-cancer AAC -0.17 2e-05
mRNA TTC38 CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA ANKRD6 CTRPv2 pan-cancer AAC -0.16 2e-05
mRNA FBXO28 CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA MB21D1 CTRPv2 pan-cancer AAC 0.17 2e-05
mRNA GOLGA2 CTRPv2 pan-cancer AAC -0.17 3e-05
mRNA CNOT9 CTRPv2 pan-cancer AAC 0.17 3e-05
mRNA RPAP2 CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA VIPR1 CTRPv2 pan-cancer AAC 0.15 3e-05
Download CSV